Correlation between Neutrophil to Monocyte Ratio, C-Reactive Protein, and D-dimer Levels among COVID-19 Patients
DOI:
https://doi.org/10.24293/ijcpml.v29i2.1992Keywords:
COVID-19, NMR, CRP, D-dimerAbstract
COVID-19 is a disease caused by the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) and leads to various clinical manifestations. This condition can cause inflammation and cardiovascular disease that can result in increased Neutrophil-to-Monocyte Ratio (NMR), C-Reactive Protein (CRP), and D-dimer. The correlation between variables needs further investigation that can be a reference. This study aimed to analyze the correlation between NMR and CRP also NMR and D-dimer in COVID-19 patients with moderate dan severe illness. The research was an observational analytical study with a cross-sectional design on 40 subjects. Data were secondary data from COVID-19 patient’s medical records in RSND Semarang. This study was carried out from April to September 2021. Correlation analysis using the Spearman Rank test with p<0.05 was considered significant. The Mean of NMR, CRP, and D-dimer was 16.69±10.65, 113.94±70.42 mg/L, and 1.72±2.35 mg/L, respectively. There was a weak positive correlation between NMR and CRP (p=0.023 and r=0.358) and there was no correlation between NMR and D-dimer (p=0.638 and r=0.077). It was expected that this knowledge about the correlation between NMR and CRP and D-dimer can help healthcare providers in planning therapy and preventing complications that may occur due to CRP and D-dimer increase.
Downloads
References
Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
Mona N. Konsep Isolasi Dalam Jaringan Sosial Untuk Meminimalisasi Efek Contagious (Kasus Penyebaran Virus Corona Di Indonesia). J Sos Hum Terap. 2020;2:117–25.
https://covid19.kemkes.go.id/. htm (accessed Mar 11, 2021)
Erlina Burhan, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, et al. Pedoman Tatalaksna Covid-19., Jakarta, Perhimpunan Dokter Paru Indonesia, Perhimpunan Dokter Spesialis Kardiovaskular Indonesia, Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia, Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia, Ikatan Dokter Anak Indonesia.2020; 103-105.
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with Covid-19 disease progression. Crit Rev Clin Lab Sci. 2020;0:1–11.
Lima DA, França JS De, Sales-neto M De, Rodrigues-mascarenhas S. Neutrophils and Covid-19 : The road so far. Int Immunopharmacol. 2020;(January). Int Immunopharmacol. 2021;90:107233.
Qin S, Jiang Y, Wei X, Liu X, Guan J, Chen Y, et al. Dynamic changes in monocytes subsets in COVID-19 patients. Hum Immunol. 2021;82(3):170–6.
Safitri M, Suromo, LB. Correlation between C-Reactive Protein Level and Blood Urea Nitrogen-Creatinine Ratio in Covid-19 Patient. IJCMPL. 2021; 28(1): 10-13.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:1–11.
Goldberg I, Shalmon D, Shteinvil R, et al. A second Creactive protein (CRP) test to detect inflammatory burst in patients with acute bacterial infections presenting with a first relatively low CRP. Medicine 2020; 99(42): e22551.
Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50(4):332–4.
Soni M, Gopalakrishnan R, Vaishya R, Prabu P. D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes Metab Syndr Clin Res Rev. 2020;14:2245–9.
Mubarak, RA, Esa T, Widaningsih Y, Bahrun U. D-dimer Analysis in Covid-19 Patients. IJCPML. 2021; 28(1): 5-9.
Rizo-t SA, Lucia AM, Flores-rebollo C. The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection ( Covid-19 ). Microorganisms. 2020;8:1560.
Lei S, Yu B. Neutrophil Percentage and Neutrophil-to-Monocyte Ratio as Independent Risk Factors in the Severity of Covid-19. 2020;1:1–14.
Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C. C-reactive protein as an early predictor of COVID-19 severity. J Med Biochem. 2020;39(4):500–7.
Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020;8(1):1–11.
Gungor B, Atici A, Baycan OF, Alici G, Ozturk F, Tugrul S, et al. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. Am J Emerg Med. 2021;39:173–9.
He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep. 2021;11(1):1–7.
Mortaz E, Alipoor SD, Adcock IM, Mumby S, Koenderman L. Update on neutrophil function in severe inflammation. Front Immunol. 2018;9:1–14.
Vatansever HS, Becer E. Relationship between IL-6 and COVID-19: To be considered during treatment. Future Virol. 2020;15(12):817–22.
Kalma K. Studi Kadar C-Reactive Protein (Crp) Pada Penderita Diabetes Melitus Tipe 2. J Media Anal Kesehat. 2018;9:1.
Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, et al. Clinical Features of COVID-19 in Patients with Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients. Hypertension. 2020;76:732–41.
Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–9.
Colling ME, Kanthi Y. COVID–19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25(5):471–8.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
